Abstract:miRNA‑gene axes have been reported to serve an important role in the carcinogenesis of pancreatic cancer (PC). The aim of the present study was to systematically identity the microRNA signature and hub molecules, as well as hub miRNA‑gene axes, and to explore the potential biomarkers and mechanisms associated with the carcinogenesis of PC. Eleven microRNA profile datasets were obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) and ArrayExpress databases, and a meta‑analysis was performed to identify the differentially expressed miRNAs (DEMs) between tumor tissue and normal tissue. Subsequently, a diagnostic regression model was constructed to identify PC based on The Cancer Genome Atlas (TCGA) miRNA sequence data by using the least absolute shrinkage and selection operator (LASSO) method. In addition, GSE41368 was downloaded, and a weighted gene co‑expression network analysis (WGCNA) was performed to obtain the gene module associated with carcinogenesis by using the TCGAbiolinks and WGCNA packages, respectively. Finally, miRNA‑gene networks were constructed and visualized using Cytoscape software, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses based on the Database for Annotation, Visualization, and Integrated Discovery (DAVID). A total of 14 DEMs were identified, and a 5‑microRNA‑based score generated by the LASSO regression model provided a high accuracy for identifying PC [area under the curve (AUC)=0.918]. In addition, 44 miRNA‑mRNA interactions were constructed, and 4 hub genes were screened on the basis of the above bioinformatic tools and databases. Furthermore, 14 biological process (BP) functions and 6 KEGG pathways were identified according to gene set enrichment analysis (GSEA). In summary, the present study applied integrated bioinformatics approaches to generate a holistic view of PC, thereby providing a basis for further clinical application of the 5‑miRNA signature and the identified hub molecules, as well as the miRNA‑gene axes, which could serve as diagnostic markers and potential treatment targets.

Combining Mrna, Microrna, Protein Expression Data And Driver Genes Information For Identifying Cancer-Related Micrornas

Combining Gene Expression And Interactions Data With Mirna Family Information For Identifying Mirna-Mrna Regulatory Modules

Identifying Cancer-Related Micrornas Based on Gene Expression Data

Identify Signature Regulatory Network for Glioblastoma Prognosis by Integrative Mrna and Mirna Co-Expression Analysis.

Integrated Analysis of miRNA and Gene Networks on Cancer Expression Data

An Integrated Mrna and Microrna Expression Signature for Glioblastoma Multiforme Prognosis.

Identification of Mirna-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput Mirna, Mrna Expression and Pathway Structure

A Two-Stage Method to Identify Joint Modules from Matched MicroRNA and Mrna Expression Data

Comprehensive analysis of miRNA-gene regulatory network with clinical significance in human cancers

MIMRDA: A Method Incorporating the miRNA and mRNA Expression Profiles for Predicting miRNA-Disease Associations to Identify Key miRNAs (microRNAs)

Identification of Differentially Expressed Micrornas and the Potential of Microrna-455-3p As a Novel Prognostic Biomarker in Glioma

A Three-Mirna Signature As A Potential Biomarker For The Diagnosis Of Glioma

Joint Analysis Of Expression Profiles From Multiple Cancers Improves The Identification Of Microrna-Gene Interactions

Identification of a 5‑microrna Signature and Hub Mirna‑mrna Interactions Associated with Pancreatic Cancer.

A New Network-Based Strategy for Predicting the Potential Mirna-Mrna Interactions in Tumorigenesis

Reconstructing the coding and non-coding RNA regulatory networks of miRNAs and mRNAs in breast cancer

Detecting pan-cancer conserved microRNA modules from microRNA expression profiles across multiple cancers.

Identification of an 8-Mirna Signature As a Potential Prognostic Biomarker for Glioma

MicroRNA Signatures Predict Prognosis of Patients with Glioblastoma Multiforme Through the Cancer Genome Atlas.

Identification of a Core miRNA-Pathway Regulatory Network in Glioma by Therapeutically Targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3

Integrative Approaches for Microrna Target Prediction: Combining Sequence Information and the Paired Mrna and Mirna Expression Profiles